Literature DB >> 12094777

ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists.

.   

Abstract

Hypertensive disease occurs in approximately 12-22% of pregnancies, and it is directly responsible for 17.6% of maternal deaths in the United States (1,2). However, there is confusion about the terminology and classification of these disorders. This bulletin will provide guidelines for the diagnosis and management of hypertensive disorders unique to pregnancy (ie, preeclampsia and eclampsia), as well as the various associated complications. Chronic hypertension has been discussed elsewhere (3).

Entities:  

Mesh:

Year:  2002        PMID: 12094777

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  191 in total

Review 1.  First trimester serum markers to predict preeclampsia.

Authors:  Berthold Huppertz; Rie Kawaguchi
Journal:  Wien Med Wochenschr       Date:  2012-05

2.  Persistent organic pollutants and pregnancy complications.

Authors:  Melissa M Smarr; Katherine L Grantz; Cuilin Zhang; Rajeshwari Sundaram; José M Maisog; Dana Boyd Barr; Germaine M Buck Louis
Journal:  Sci Total Environ       Date:  2016-02-12       Impact factor: 7.963

3.  Genetic variants, immune function, and risk of pre-eclampsia among American Indians.

Authors:  Lyle G Best; Melanie Nadeau; Kylie Davis; Felicia Lamb; Shellee Bercier; Cindy M Anderson
Journal:  Am J Reprod Immunol       Date:  2011-10-17       Impact factor: 3.886

4.  Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1.

Authors:  Ori Nevo; Nima Soleymanlou; Yuan Wu; Jing Xu; John Kingdom; Ariel Many; Stacy Zamudio; Isabella Caniggia
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-04-20       Impact factor: 3.619

5.  Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsia, Pregnancy-induced Hypertension, and Proteinuria.

Authors:  H Lehnen; N Mosblech; T Reineke; A Puchooa; I Menke-Möllers; U Zechner; U Gembruch
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-05       Impact factor: 2.915

6.  Congress on women's health Trudy Bush lecture 2014: new insights into sex Hormones and Cardiovascular disease.

Authors:  Virginia M Miller
Journal:  J Womens Health (Larchmt)       Date:  2014-12       Impact factor: 2.681

7.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

8.  Serum leptin and ghrelin concentrations of maternal serum, arterial and venous cord blood in healthy and preeclamptic pregnant women.

Authors:  S Aydin; S P Guzel; S Kumru; Suna Aydin; O Akin; E Kavak; I Sahin; M Bozkurt; I Halifeoglu
Journal:  J Physiol Biochem       Date:  2008-03       Impact factor: 4.158

9.  A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Tinnakorn Chaiworapongsa; Offer Erez; Pooja Mittal; Edi Vaisbuch; Shali Mazaki-Tovi; Francesca Gotsch; Samuel S Edwin; Ricardo Gomez; Lami Yeo; Agustin Conde-Agudelo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

10.  Epworth sleepiness scale scores and adverse pregnancy outcomes.

Authors:  Ghada Bourjeily; Rana El Sabbagh; Peter Sawan; Christina Raker; Carren Wang; Beth Hott; Mariam Louis
Journal:  Sleep Breath       Date:  2013-02-19       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.